Cargando…
Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
The prevalence of nonalcoholic fatty liver disease (NAFLD) has been significantly increased due to the global epidemic of obesity. The disease progression from simple steatosis (NAFL) to nonalcoholic steatohepatitis (NASH) is closely linked to inflammation, insulin resistance, and dysbiosis. Althoug...
Autores principales: | Xue, Rui, Su, Lianyong, Lai, Shengyi, Wang, Yanyan, Zhao, Derrick, Fan, Jiangao, Chen, Weidong, Hylemon, Phillip B., Zhou, Huiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616422/ https://www.ncbi.nlm.nih.gov/pubmed/34831031 http://dx.doi.org/10.3390/cells10112806 |
Ejemplares similares
-
Long Noncoding RNA H19: A Novel Oncogene in Liver Cancer
por: Wang, Yanyan, et al.
Publicado: (2023) -
Zhuyu Pill Alleviates Nonalcoholic Fatty Liver Disease
by Regulating Bile Acid Metabolism through the Gut–Liver Axis
por: Xu, Lu, et al.
Publicado: (2023) -
Hepatic Branch Vagotomy Modulates the Gut-Liver-Brain Axis in Murine Cirrhosis
por: Zhang, Yuan, et al.
Publicado: (2021) -
Bile acid-mediated signaling in cholestatic liver diseases
por: Zeng, Jing, et al.
Publicado: (2023) -
Gut-liver axis modulation of Panax notoginseng saponins in nonalcoholic fatty liver disease
por: Xu, Yu, et al.
Publicado: (2021)